Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype

Show other versions (1)

Bibliographic Details
Main Authors:	Burns, A, Clifford, R, Dreau, H, Hatton, C, Henderson, S, Taylor, J, Schuh, A
Format:	Conference item
Published:	2012

Similar Items

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
by: Burns, A, et al.
Published: (2012)

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
by: Clifford, R, et al.
Published: (2012)

MicroRNA expression in chronic lymphocytic leukaemia.
by: Lawrie, C, et al.
Published: (2009)

Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
by: Bruce, DR, et al.
Published: (2014)

Immunoglobulin replacement in chronic lymphocytic leukaemia.
by: Bunch, C
Published: (1988)

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
by: Oscier, D, et al.
Published: (2012)

Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
by: Rees-Unwin, K, et al.
Published: (2010)

Intravenous immune globulin in chronic lymphocytic leukaemia.
by: Gamm, H, et al.
Published: (1994)

Predictors of infection in chronic lymphocytic leukaemia (CLL).
by: Griffiths, H, et al.
Published: (1992)

Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
by: Buchanan, J, et al.
Published: (2017)

Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment
by: Buchanan, J, et al.
Published: (2016)

The study of DNA methylation anomalies in chronic lymphocytic leukaemia
by: Roy, NBA
Published: (2011)

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
by: Parker, H, et al.
Published: (2016)

State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.
by: Clifford, R, et al.
Published: (2012)

Collaborative meta-analysis of randomised trials in chronic lymphocytic leukaemia (CLL)
by: Binet, J, et al.
Published: (1998)

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
by: Chowdhury, O, et al.
Published: (2011)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
by: Burns, A, et al.
Published: (2017)

Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
by: Lander, Eric Steven
Published: (2017)

Characterisation of the mutational landscape of chronic lymphocytic leukaemia using genome-wide approaches
by: Alsolami, R
Published: (2017)

The value of subtyping in studies of irradiation and human leukaemia.
by: Darby, S
Published: (1985)

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
by: Chapel, H, et al.
Published: (1994)

Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis (Protocol)
by: Skoetz, N, et al.
Published: (2016)

Chronic neutrophilic leukaemia.
by: Gan, G.G., et al.
Published: (2007)

Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?
by: Alsolami, R, et al.
Published: (2013)

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3
by: Catovsky, D, et al.
Published: (1998)

Incurable, invisible and inconclusive: watchful waiting for chronic lymphocytic leukaemia and implications for doctor-patient communication.
by: Evans, J, et al.
Published: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
by: Steurer, M, et al.
Published: (2006)

Prognostic models for newly‐diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta‐analysis
by: Kreuzberger, N, et al.
Published: (2020)

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
by: Clifford, R, et al.
Published: (2014)

MEASUREMENT OF MICRORNA EXPRESSION LEVELS BY QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION IS A USEFUL TOOL TO PREDICT OUTCOME IN PATIENTS WITH B CELL CHRONIC LYMPHOCYTIC LEUKAEMIA
by: Schuh, A, et al.
Published: (2009)

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.
by: Bosanquet, A, et al.
Published: (1999)

The significance of deletion architecture, ATM mutational status and genomic complexity in 11q deleted Chronic Lymphocytic Leukaemia
by: Rose-Zerilli, M, et al.
Published: (2012)

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
by: Schuh, A, et al.
Published: (2012)

Targeted mass spectrometry reveals interferon-dependent eicosanoid and fatty acid alterations in chronic myeloid leukaemia
by: Scott, HC, et al.
Published: (2023)

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
by: Kasar, S., et al.
Published: (2017)

Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
by: Richards, S
Published: (2005)

Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
by: Bosanquet, A, et al.
Published: (2009)

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
by: Berndt, S, et al.
Published: (2013)